CalciMedica is trading 5.14% up at $2.25 after Stonepine Capital Management expanded its position on August 19, 2026, bringing ownership to 6.00%.
- The position increase totaled 305,418 shares.
- The investment is being highlighted as a potential driver of the recent rally.
- The move follows extreme post-reverse-split volatility, including a 360.81% gain on August 31, while broader biotechnology and major U.S. indexes are declining.